PINL:ZLDPF - Post Discussion
Post by
whytestocks on Jun 06, 2024 2:30pm
Zealand Pharma announces that Boehringer Ingelheim will pres
News; $ZLDPF Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASLCompany announcement - No. 29 / 2024 Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL Copenhagen, Denmark, June 6, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) today announced that an embargoed ...
ZLDPF - Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL
Be the first to comment on this post